Clinical outcomes of metabolically healthy obesity (MHO) remain controversial in the previous studies using body mass index (BMI) 
This might be due to the limitations of BMI, such as an inability to discriminate between muscle and fat or to identify fat location. 2 Recent studies reported that A Body Shape Index (ABSI) has an inverse relationship with fat-free mass and can be used for screening sarcopenic obesity. and Nutrition Examination Survey. 5 Additional template for other races and ethnicities in the United States will be available soon.
